Ms. Groll leads operations, go-to-market strategy and organizational scale at Nabla, a clinical AI company now used by tens of thousands of clinicians across hundreds of healthcare organizations and supporting over 30 million patient encounters annually. The company boasts an average monthly recurring revenue growth of 20% and $120 million in total funding, including a $70 million Series C. Ms. Groll pioneered Nabla’s co-development model with health systems, ensuring continuous clinician feedback informs product design and deployment, and drove strategic partnerships including integrations with Epic, athenahealth and Cerner. At leading health systems, Nabla has contributed to up to a 50% reduction in documentation time and meaningful decreases in clinician burnout. She also helped establish governance frameworks contributing to the Coalition for Health AI. Ms. Groll was named to Inc.com’s “Female Founders 500” for 2026 and to Crain’s New York Business‘ “31 Notable Leaders in Healthcare Technology,” and serves as a board member and investor at The Galion Project.
